152 related articles for article (PubMed ID: 19856049)
21. Three cytotoxic drugs combined with pelvic radiation and as maintenance chemotherapy for patients with squamous cell carcinoma of the anus (SCCA): long-term follow-up of a phase II pilot study using 5-fluorouracil, mitomycin C and cisplatin.
Sebag-Montefiore D; Meadows HM; Cunningham D; Plowman PN; Hurman DC; Davidson N; Grieve R; Levine E; Glynne-Jones R
Radiother Oncol; 2012 Aug; 104(2):155-60. PubMed ID: 22857859
[TBL] [Abstract][Full Text] [Related]
22. Analysis of outcomes achieved with squamous cell carcinomas of the anus in a single university hospital over the last two decades: Clinical response rate, relapse and survival of 190 patients.
Gravante G; Stephenson JA; Elshaer M; Osman A; Vasanthan S; Mullineux JH; Gani MAD; Sharpe D; Yeung J; Norwood M; Miller A; Boyle K; Hemingway D
J Surg Oncol; 2018 Feb; 117(2):269-274. PubMed ID: 28891266
[TBL] [Abstract][Full Text] [Related]
23. Long-standing Crohn's disease and its implication on anal squamous cell cancer management.
Lightner AL; Moncrief SB; Smyrk TC; Pemberton JH; Haddock MG; Larson DW; Dozois EJ; Mathis KL
Int J Colorectal Dis; 2017 May; 32(5):661-666. PubMed ID: 28293746
[TBL] [Abstract][Full Text] [Related]
24. Challenges of improving treatment outcomes for colorectal and anal cancers in Japan: the Colorectal Cancer Study Group (CCSG) of the Japan Clinical Oncology Group (JCOG).
Ouchi A; Shida D; Hamaguchi T; Takashima A; Ito Y; Ueno H; Ishiguro M; Takii Y; Ikeda S; Ohue M; Fujita S; Shiozawa M; Kataoka K; Ito M; Tsukada Y; Akagi T; Inomata M; Shimada Y; Kanemitsu Y
Jpn J Clin Oncol; 2020 Apr; 50(4):368-378. PubMed ID: 32115643
[TBL] [Abstract][Full Text] [Related]
25. Intensity-modulated radiotherapy vs. conventional radiotherapy in the treatment of anal squamous cell carcinoma: a propensity score analysis.
Dasgupta T; Rothenstein D; Chou JF; Zhang Z; Wright JL; Saltz LB; Temple LK; Paty PB; Weiser MR; Guillem JG; Nash GM; Goodman KA
Radiother Oncol; 2013 May; 107(2):189-94. PubMed ID: 23692961
[TBL] [Abstract][Full Text] [Related]
26. Does gap-free intensity modulated chemoradiation therapy provide a greater clinical benefit than 3D conformal chemoradiation in patients with anal cancer?
Dewas CV; Maingon P; Dalban C; Petitfils A; Peignaux K; Truc G; Martin E; Khoury C; Dewas S; Créhange G
Radiat Oncol; 2012 Nov; 7():201. PubMed ID: 23190693
[TBL] [Abstract][Full Text] [Related]
27. Chemoradiotherapy with or without consolidation chemotherapy using cisplatin and 5-fluorouracil in anal squamous cell carcinoma: long-term results in 31 patients.
Cho BC; Ahn JB; Seong J; Roh JK; Kim JH; Chung HC; Sohn JH; Kim NK
BMC Cancer; 2008 Jan; 8():8. PubMed ID: 18194582
[TBL] [Abstract][Full Text] [Related]
28. Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell Carcinoma.
Mouw KW; Cleary JM; Reardon B; Pike J; Braunstein LZ; Kim J; Amin-Mansour A; Miao D; Damish A; Chin J; Ott PA; Fuchs CS; Martin NE; Getz G; Carter S; Mamon HJ; Hornick JL; Van Allen EM; D'Andrea AD
Clin Cancer Res; 2017 Jun; 23(12):3214-3222. PubMed ID: 27852700
[No Abstract] [Full Text] [Related]
29. Utility of CYP2D6 copy number variants as prognostic biomarker in localized anal squamous cell carcinoma.
Trilla-Fuertes L; Gámez-Pozo A; Nogué M; Busquier I; Arias F; López-Campos F; Fernández-Montes A; Ruiz A; Velázquez C; Martín-Bravo C; Pérez-Ruiz E; Asensio E; Hernández-Yagüe X; Rodrigues A; Ghanem I; López-Vacas R; Hafez A; Arias P; Dapía I; Solís M; Dittmann A; Ramos R; Llorens C; Maurel J; Campos-Barros Á; Fresno Vara JÁ; Feliu J
Cancer; 2023 Aug; 129(16):2581-2592. PubMed ID: 37096763
[TBL] [Abstract][Full Text] [Related]
30. Twenty-five-year experience with radical chemoradiation for anal cancer.
Tomaszewski JM; Link E; Leong T; Heriot A; Vazquez M; Chander S; Chu J; Foo M; Lee MT; Lynch CA; Mackay J; Michael M; Tran P; Ngan SY
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):552-8. PubMed ID: 22019078
[TBL] [Abstract][Full Text] [Related]
31. Local excision versus radical surgery for anal squamous cell carcinoma: a multicenter study in Japan.
Murai S; Nozawa H; Yamada K; Saiki Y; Sasaki K; Murono K; Emoto S; Matsuzaki H; Yokoyama Y; Abe S; Nagai Y; Yoshioka Y; Shinagawa T; Sonoda H; Sugihara K; Ajioka Y; Ishihara S
Int J Clin Oncol; 2024 Jun; 29(6):813-821. PubMed ID: 38526623
[TBL] [Abstract][Full Text] [Related]
32. [Multidisciplinary Treatment for Squamous Cell Carcinoma of the Anal Canal].
Karasawa H; Ohnuma S; Watanabe K; Tsuchiya T; Imoto H; Aoki T; Kudoh K; Tanaka N; Nagao M; Abe T; Musha H; Motoi F; Kamei T; Naitoh T; Unno M
Gan To Kagaku Ryoho; 2017 Nov; 44(12):2009-2010. PubMed ID: 29394850
[TBL] [Abstract][Full Text] [Related]
33. Definitive Chemoradiotherapy for Anal Carcinoma: Long-Term Results Based on Consistent Time-to-Event Endpoints.
De Felice F; Martinetti MT; Orelli S; Bulzonetti N; Musio D; Tombolini V
Oncology; 2018; 94(1):25-30. PubMed ID: 28918425
[TBL] [Abstract][Full Text] [Related]
34. Treatment of squamous cell carcinoma of external auditory canal: A tertiary cancer centre experience.
Gandhi AK; Roy S; Biswas A; Raza MW; Saxena T; Bhasker S; Sharma A; Thakar A; Mohanti BK
Auris Nasus Larynx; 2016 Feb; 43(1):45-9. PubMed ID: 26165629
[TBL] [Abstract][Full Text] [Related]
35. Management of anal cancer patients - a pattern of care analysis in German-speaking countries.
Martin D; von der Grün J; Rödel C; Fokas E
Radiat Oncol; 2020 May; 15(1):122. PubMed ID: 32450863
[TBL] [Abstract][Full Text] [Related]
36. Phase I study of cetuximab in combination with 5-fluorouracil, mitomycin C and radiotherapy in patients with locally advanced anal cancer.
Leon O; Guren MG; Radu C; Gunnlaugsson A; Johnsson A
Eur J Cancer; 2015 Dec; 51(18):2740-6. PubMed ID: 26597443
[TBL] [Abstract][Full Text] [Related]
37. Management of anal intraepithelial neoplasia and anal squamous cell carcinoma at a tertiary referral centre with a dedicated infectious diseases unit: an 18-year review.
Power Foley M; Kelly ME; Kerr C; Kennedy C; Gallagher D; Gillham C; Mehigan BJ; McCormick PH; Bergin C; Larkin JO
Int J Colorectal Dis; 2020 Oct; 35(10):1855-1864. PubMed ID: 32500433
[TBL] [Abstract][Full Text] [Related]
38. Recurrent squamous cell carcinoma of the anal canal. Predictors of initial treatment failure and results of salvage therapy.
Longo WE; Vernava AM; Wade TP; Coplin MA; Virgo KS; Johnson FE
Ann Surg; 1994 Jul; 220(1):40-9. PubMed ID: 8024357
[TBL] [Abstract][Full Text] [Related]
39. Salvage surgery for residual primary and locally recurrent anal squamous cell carcinoma after chemoradiotherapy in HIV-positive individuals.
Cunin L; Alfa-Wali M; Turner J; Bower M; Ion L; Allen-Mersh T
Ann Surg Oncol; 2014 Feb; 21(2):527-32. PubMed ID: 24242676
[TBL] [Abstract][Full Text] [Related]
40. Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes.
Klas JV; Rothenberger DA; Wong WD; Madoff RD
Cancer; 1999 Apr; 85(8):1686-93. PubMed ID: 10223561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
